Medcura company logo
Analyst Briefing Submitted
medcurainc.com

Founded Year

2007

Stage

Convertible Note | Alive

Total Raised

$20.52M

Last Raised

$3.49M | 7 mos ago

About Medcura

Medcura develops and markets biomaterials that aim to achieve hemostasis, which is the halting of blood loss.

Medcura Headquarter Location

5650 Rivertech Ct Suite S

Riverdale, Maryland, 20737,

United States

240-684-8801

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Medcura's Products & Differentiation

See Medcura's products and how their products differentiate from alternatives and competitors

  • RapidSeal

    High-Performance, Antibacterial 1st Aide

    Differentiation

    Rapid antibacterial sealing that's easy to apply and remove 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Medcura

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medcura is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

A

Advanced Materials

1,244 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

H

Health IT

7,900 items

Medcura Patents

Medcura has filed 8 patents.

The 3 most popular patent topics include:

  • Polysaccharides
  • Polymers
  • Coagulation system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/3/2019

3/15/2022

Polymers, EC 3.2.1, Polymer chemistry, EC 2.4.1, Polysaccharides

Grant

Application Date

10/3/2019

Grant Date

3/15/2022

Title

Related Topics

Polymers, EC 3.2.1, Polymer chemistry, EC 2.4.1, Polysaccharides

Status

Grant

Latest Medcura News

Medcura Expands its Senior Leadership Team and Appoints Leading Neurosurgeon Dr. Kenneth Renkens as Chief Medical Officer

May 2, 2022

RIVERDALE, Md., April 26, 2022 /PRNewswire/ -- Medcura, Inc., a commercial-stage medical device company, today announced the expansion of its senior management team to include Dr. Kenneth Renkens as its Chief Medical Officer. Dr. Renkens is a thought-leading neurosurgeon who co-founded the Indiana Spine Group and has been involved in the development and commercial success of numerous innovative products now widely used in operating rooms around the world. Chosen for his deep expertise in neurosurgery and past involvement with numerous implantable surgical innovations, Dr. Renkens joins an experienced team with a demonstrated track record of execution in delivering groundbreaking hemostat innovations. The Medcura team is now narrowly focusing its attention on bringing more disruptive technology to the Operating Room (OR).

Medcura Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Medcura Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.